Search Results

You searched for : LatestPharmaNewsUpdate  

Asymchem Acquires Snapdragon Chemistry

Latest Corporate News update ; Pharma...
Feb 14

Health Decisions and OncoBay Clinical partners for development services in women's oncology

...
Dec 03

Impel Neuropharma reports FDA submission of new drug application For INP104

INP104 is indicated in treatment of acute migraine...
Nov 10

EIP Pharma Announces Presentation of Positive Clinical Trial Results with Neflamapimod

Results were presented at the 13th Clinical Trials in Alzheimer's Disease (CTAD) Meeting...
Nov 09

Lonza announces agreement to manufacture AstraZeneca’s COVID-19 long-acting antibody combination

Lonza and AstraZeneca collaborates to handle Covid challenge...
Nov 04

Novartis expands Kymriah manufacturing footprint in Asia

first-ever approved site for commercial CAR-T cell therapy manufacturing in Asia...
Oct 31

CStone and LegoChem Biosciences enter into global licensing agreement

CStone is a biopharmaceutical company focused on the development and commercialization of innovative immuno-oncology and precision drugs ...
Oct 30

NBE-Therapeutics starts first clinical Study of Anti-ROR1 Antibody-Drug conjugate for patients with solid tumors

Anti-tumor immune memory and iADC platform are showing results ...
Oct 27

Passage Bio’s PBGM01 receives Orphan Drug Designation from EMA for treatment of GM1 Gangliosidosis

...
Oct 27

Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus

Sai Life expands organizational transformation areas...
Oct 27

Aimmune Receives Positive CHMP opinion on PALFORZIA ; treatment of patients with peanut allergy

PALFORZIA recieves CHMP for Europe...
Oct 19

Helix Technologies, Inc. and Medical Outcomes Research Analytics, LLC to Combine

Forian Inc. to Become Industry Leading Information, Analytics and Technology Provider for Healthcare and Cannabis Industries ...
Oct 19

Lancet debunks Lopinavir- Ritonavir as effective treatment for patients hospitalized with COVID-19

Antiviral drugs are under lens for their effectiveness...
Oct 06

Bristol Myers Squibbs get FDA approval for Opdivo and Yervoy : Malignant Pleural Mesothelioma

Opdivo + Yervoy is the first new systemic therapy in over 15 years to be approved by the FDA ...
Oct 03

HUYA Bioscience announces orphan drug Designation for HBI-8000 in Japan

HBI-8000 for Monotherapy Adult T-cell Leukemia-Lymphoma ATL ...
Oct 01

Ajinomoto Bio-Pharma Services and DNDi Partner to develop Critical Immunomodulator

Partners will develop Critical Immunomodulator for Cutaneous Leishmaniasis Therapeutic...
Sep 30

FDA grants IND Approval for Stemedica's itMSC Therapy for COVID-19 Patients

The study will enrol up to 40 patients into two cohorts, randomized 1:1 to receive the active study drug plus standard treatment or placebo...
Sep 29

China's Kangtai gets approval for clinical trial of coronavirus vaccine candidate

China's Kangtai Biological Products cleared for human trial while Chinese Academy of Medical Sciences vaccine candidate is in mid-stage trial....
Sep 29

Zymo Research granted CE IVD Mark for sample collection devices

Zymo Research was granted the CE IVD mark for its DNA/RNA Shield reagent and collection devices. ...
Sep 28

Lupin Launches Fosaprepitant for injection ; emetogenic cancer chemotherapy

150 mg Single-Dose Vial, having received an approval from the United States Food and Drug Administration (U.S. FDA) earlier....
Sep 28

Hetero's new Favivir packaging for Covid-19 with 800 mg dosage cuts pill burden

The higher strength of Favipiravir 800 mg from Hetero has been approved by the Drug Controller General of India ...
Sep 26

Millendo Therapeutics reports First-in-Human Clinical Trial of MLE-301 for VSM

VMS, is commonly known as hot flashes and night sweats, in menopausal women....
Sep 26

Avifavir: Russia declares supply to 17 more countries with Covid-19 drug

Russia pushes the cheapest covid drug Avifavir...
Sep 25

Vivet Therapeutics and Pfizer Inc. Enter into Manufacturing Agreement for Wilson Disease treatment

Manufacturing agreement is for Vivet’s Investigational Gene Therapy for Wilson Disease...
Sep 24

Genocea announces FDA acceptance of GEN-011 IND Application

...
Sep 23

25 Matching result(s) found!